Abbott Laboratories (ABT) vs Eli Lilly and Company (LLY)
LLY leads on 10 of 17 compared metrics, though ABT is the cheaper stock.
A side-by-side comparison of Abbott Laboratories and Eli Lilly and Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — ABT vs LLY
growth of $100 · last 30yABT +814.7%LLY +3468.5%LLY compounded faster
ABT LLY
ABT vs LLY: by the numbers
- •LLY is the larger company ($1.07T vs $153.59B market cap).
- •ABT trades at the lower earnings multiple (24.56 vs 40.25 P/E).
- •LLY converts more revenue to profit (34.98% vs 13.91% net margin).
- •LLY grew revenue faster over the past five years (23.17% vs 3.87% CAGR).
- •ABT pays the higher dividend yield (2.77% vs 0.57%).
Which is better, ABT or LLY?
Metric tally: ABT 7 · LLY 10It depends on what you're optimizing for:
ValueABT(lower P/E)
GrowthLLY(faster 5Y revenue CAGR)
IncomeABT(higher dividend yield)
QualityLLY(higher ROIC)
Metrics side by side
Valuation
| Metric | ABT | LLY |
|---|---|---|
| P/E ratio | 24.56● | 40.25 |
| Forward P/E | 14.56● | 25.41 |
| P/S ratio | 3.41● | 14.05 |
| P/B ratio | 2.96● | 32.54 |
| PEG ratio | 2.99 | 0.49● |
| EV / EBITDA | 17.30● | 31.47 |
| FCF yield | 4.79%● | 1.34% |
Profitability
| Metric | ABT | LLY |
|---|---|---|
| Gross margin | 56.38% | 83.51%● |
| Operating margin | 18.17% | 45.87%● |
| Net margin | 13.91% | 34.98%● |
| ROE | 12.06% | 81.01%● |
| ROIC | 8.43% | 30.20%● |
Dividends
| Metric | ABT | LLY |
|---|---|---|
| Dividend yield | 2.77%● | 0.57% |
| Payout ratio | 65.24% | 28.09% |
Growth (annualized)
| Metric | ABT | LLY |
|---|---|---|
| Revenue CAGR (5Y) | 3.87% | 23.17%● |
| EPS CAGR (5Y) | 8.22% | 28.88%● |
| FCF CAGR (5Y) | -0.61% | 19.54%● |
| Total return CAGR (5Y) | -2.49% | 39.57%● |
Frequently asked
- Which is better, ABT or LLY?
- It depends on your goal. value: ABT (lower P/E); growth: LLY (faster 5Y revenue CAGR); income: ABT (higher dividend yield); quality: LLY (higher ROIC). Across all compared metrics, LLY leads 10 to 7.
- Is ABT or LLY cheaper?
- On trailing earnings, ABT is cheaper: ABT trades at a 24.56 P/E and LLY at 40.25.
- Which has grown faster, ABT or LLY?
- Over the past five years, LLY grew revenue faster — ABT at a 3.87% CAGR versus LLY at 23.17%.
- Does ABT or LLY pay a bigger dividend?
- ABT yields 2.77% and LLY yields 0.57% based on trailing dividends and the latest price.
- Is ABT or LLY more profitable?
- LLY runs the higher net margin — ABT at 13.91% versus LLY at 34.98%.
- Which has been the better investment, ABT or LLY?
- Over the past 10-year, LLY delivered the higher annualized total return — ABT at 10.72% versus LLY at 33.50%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Abbott Laboratories P/E ratioEli Lilly and P/E ratioAbbott Laboratories dividend yieldEli Lilly and dividend yieldAbbott Laboratories ROEEli Lilly and ROEAbbott Laboratories operating marginEli Lilly and operating marginAbbott Laboratories revenue growthEli Lilly and revenue growthAbbott Laboratories free cash flowEli Lilly and free cash flow
Abbott Laboratories & Eli Lilly and appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.